Ohcanbohtosat - Carmelo Rizzari

Aiddostahte ozu
  1. 1
    Asparaginase pharmacokinetics and implications of therapeutic drug monitoring

    Asparaginase pharmacokinetics and implications of therapeutic drug monitoring Dahkki Barbara L. Asselin, Carmelo Rizzari

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Optimizing asparaginase therapy for acute lymphoblastic leukemia

    Optimizing asparaginase therapy for acute lymphoblastic leukemia Dahkki Carmelo Rizzari, Valentino Conter, Jan Starý, Antonella Colombini, Anja Moericke, Martin Schrappe

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati

    Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy.... Dahkki Adriana Balduzzi, Erica Brivio, Attilio Rovelli, Carmelo Rizzari, Serena Gasperini, Maria Luisa Melzi, Valentino Conter, Andrea Biondi

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols

    Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols Dahkki Andrea Pession, Roberto Rondelli, Giuseppe Basso, Carmelo Rizzari, A. M. Testi, Franca Fagioli, Piero De Stefano, Franco Locatelli

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia

    Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia Dahkki Maurizio Aricò, Giuseppe Basso, Luigi Zanesco, Franco Mandelli, Carmelo Rizzari, Giuseppe Masera, R. Colella, Elena Barisone, Roberto Rondelli, Andrea Pession

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    L‐asparaginase treatment in acute lymphoblastic leukemia

    L‐asparaginase treatment in acute lymphoblastic leukemia Dahkki Rob Pieters, Stephen P. Hunger, Joachim Boos, Carmelo Rizzari, Lewis B. Silverman, André Baruchel, Nicola Goekbuget, Martin Schrappe, Ching‐Hon Pui

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

    Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia Dahkki Franco Locatelli, Anna Maria Testi, Maria Ester Bernardo, Carmelo Rizzari, Alice Bertaina, Pietro Merli, Andrea Pession, Eugenia Giraldi, Rosanna Parasole, Walter Barberi, Marco Zecca

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    The Healthcare Professionals’ and Patient Advocates’ Perspectives on the Care for Children with Cancer in Europe—A Report from the ESCALIER Project

    The Healthcare Professionals’ and Patient Advocates’ Perspectives on the Care for Children with Cancer in Europe—A Report from the ESCALIER Project Dahkki Maria Otth, Marko Ocokoljic, Theodora Armenkova, İrina Ban, Samira Essiaf, Maximilian Hopfgartner, Lejla Kamerić, Pamela Kearns, Γεωργία Κόκκινου, Carmelo Rizzari, Carina Schneider, Katrin Scheinemann

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II

    Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II Dahkki Maurizio Aricò, Maria Grazia Valsecchi, Valentino Conter, Carmelo Rizzari, Andrea Pession, Chiara Messina, Elena Barisone, Vincenzo Poggi, Giulio Rossi, Franco Locatelli, Maria Concetta Micalizzi, Giuseppe Basso, Giuseppe Masera

    Almmustuhtton 2002
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

    Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation Dahkki Inge M. van der Sluis, Lynda M. Vrooman, Rob Pieters, André Baruchel, Gabriele Escherich, Nick Goulden, Veerle Mondelaers, Juliano S. Toledo, Carmelo Rizzari, Lewis B. Silverman, James A. Whitlock

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure

    L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure Dahkki Carmelo Rizzari, Massimo Zucchetti, Valentino Conter, Luisa Diomede, Alessandra De Bruno, Livio Maria Gavazzi, Maria Cristina Paganini, Paola Sparano, Luca Lo Nigro, Maurizio Aricò, Massimo Milani, M. D’lncalci

    Almmustuhtton 2000
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Ancestry and pharmacogenetics of antileukemic drug toxicity

    Ancestry and pharmacogenetics of antileukemic drug toxicity Dahkki Shinji Kishi, Cheng Cheng, Deborah French, Deqing Pei, Soma Das, Edwin H. Cook, Nobuko Hijiya, Carmelo Rizzari, Gary L. Rosner, Tony Frudakis, Ching‐Hon Pui, William E. Evans, Mary V. Relling

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Long-Term Results of a Randomized Trial on Extended Use of High Dose <scp>l</scp>-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia

    Long-Term Results of a Randomized Trial on Extended Use of High Dose <scp>l</scp>-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia Dahkki Andrea Pession, Maria Grazia Valsecchi, Giuseppe Masera, Willem A. Kamps, Edina Magyarosy, Carmelo Rizzari, Elisabeth R. van Wering, Luca Lo Nigro, Anna van der Does, Franco Locatelli, Giuseppe Basso, Maurizio Aricò

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the <scp>AIEOP</scp>‐<scp>AML</scp> 2002/01 study protocol

    Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the <scp>AIEOP</scp>‐<scp>AML</scp> 2... Dahkki Barbara Buldini, Frida Rizzati, Riccardo Masetti, Franca Fagioli, Giuseppe Menna, Concetta Micalizzi, Maria Caterina Putti, Carmelo Rizzari, Nicola Santoro, Marco Zecca, Silvia Disarò, Roberto Rondelli, Pietro Merli, Martina Pigazzi, Andrea Pession, Franco Locatelli, Giuseppe Basso

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium

    Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Can... Dahkki C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, Donna L. Lancaster, Thomas Lehrnbecher, Vincent H. J. van der Velden, Berna Beverloo, Monique L. den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis C. Strauss, André Baruchel, Pamela Kearns

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

    The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01 Dahkki Ursula Creutzig, Martin Zimmermann, Michael Dworzak, B Gibson, R. Y. J. Tamminga, Jonas Abrahamsson, Sy Ha, Henrik Hasle, A. Maschan, Y. Bertrand, G Leverger, Christine von Neuhoff, Bassem I. Razzouk, Carmelo Rizzari, Petr Smíšek, Owen Smith, Birgit Stark, Dirk Reinhardt, Gertjan J.L. Kaspers

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

    Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia Dahkki Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakaş, Francisco Bautista, Stéphane Ducassou, Keon Hee Yoo, C. Michel Zwaan, Frédéric Millot, Paola Aimone, Alex Allepuz, Sara Quenet, Florence Hourcade‐Potelleret, Sabine Hertle, Darintr Sosothikul

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Children with cancer in the time of COVID‐19: An 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy

    Children with cancer in the time of COVID‐19: An 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy Dahkki Andrea Ferrari, Marco Zecca, Carmelo Rizzari, Fulvio Porta, Massimo Provenzi, Maddalena Marinoni, Richard Fabian Schumacher, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Stefano Chiaravalli, Francesca Compagno, Federica Bruni, C. Piccolo, Laura Rachele Bettini, Mariella D’Angiò, Giulia Ferrari, Andrea Biondi, Maura Massimino, Adriana Balduzzi

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia

    Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia Dahkki Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Noemi Mergen, Abeera Mohammad, William Kormany, Cornelia Eckert, Anja Möricke, Mary Sartor, Ondřej Hrušák, Christina Peters, Vaskar Saha, Luciana Vinti, Arend von Stackelberg

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

    Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis Dahkki Franco Locatelli, Michael B. Jordan, Carl E. Allen, Simone Cesaro, Carmelo Rizzari, Anupama Rao, Barbara Degar, Timothy Garrington, Julián Sevilla, M C Putti, Franca Fagioli, Martina Ahlmann, José Luís Dapena, M M Henry, Fabrizio De Benedetti, Alexei A. Grom, G Lapeyre, Philippe Jacqmin, Maria Ballabio, Cristina de Min

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: